UROY Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Uranium Royalty Corp (UROY) is not a strong buy for a beginner, long-term investor at this moment. While the stock has positive catalysts such as an analyst upgrade and a diversified portfolio, the financial performance shows a significant decline in net income and EPS. The technical indicators and options data do not suggest a strong bullish sentiment, and there are no proprietary trading signals to support an immediate buy decision. The investor may consider waiting for clearer entry signals or improved financial performance before investing.
The MACD histogram is positive at 0.0268, indicating a slight bullish momentum, but it is contracting. RSI is neutral at 53.702, suggesting no clear overbought or oversold conditions. Moving averages are converging, showing no strong trend. Key support is at 3.526, and resistance is at 4.072.
Raymond James upgraded the stock to Outperform with a price target increase to C$6.25, citing a high-margin royalty model, diversified portfolio, and solid balance sheet.
No significant trading trends from hedge funds or insiders. Financial performance shows a sharp decline in net income (-202.67%) and EPS (-200.00%) YoY. The stock trend analysis suggests a potential decline in the short term.
In Q3 2026, revenue increased significantly by 416400.00% YoY to $16.66M. However, net income dropped by -202.67% YoY to $1.96M, and EPS fell by -200.00% YoY to $0.01. Gross margin remained stable at 28.59%.
Raymond James upgraded the stock to Outperform from Market Perform with a price target increase from C$5.75 to C$6.25, citing lower risk exposure and strong portfolio diversification.
